News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biogen Idec, Inc. (Massachusetts) (BIIB) To Present On Best Practices For Leveraging Quality And Regulatory Compliance Management Software On Apple iPads


3/21/2014 9:15:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

JERSEY CITY, NJ--(Marketwired - March 20, 2014) - QUMAS, an Accelrys company (NASDAQ: ACCL), today announced that it will host a live, complimentary webinar highlighting how to save time, money, and materials and how to increase compliance across Manufacturing by leveraging QUMAS Quality and Regulatory Compliance Management Software on Apple iPads. The webinar will offer expert advice from Gregory Chua, Senior Manufacturing Support Associate at Biogen Idec and Murtuza Vasowalla, Director of Global Solutions Consulting at QUMAS.

The webinar will detail how industry leader Biogen Idec has transformed its manufacturing operations by replacing a system that utilized manual processes and paper documents with an electronic solution for managing quality and compliance.

This one-hour webinar will be held on Tuesday, March 25, from 12:00pm ET to 1:00pm ET and will cover:

  • Review of old paper methods
  • Piloting of devices
  • User acceptance / feedback
  • Implementation plan
  • On-going enhancements
  • Demonstration

For more information and to register for the webinar, visit http://www.qumas.com/webinars/upcoming. The event will also be recorded and available for on-demand viewing at http://www.qumas.com.

About QUMAS

QUMAS is the leader in Enterprise Compliance Solutions with more than 270 global customer deployments and two decades of experience helping companies in highly regulated industries. QUMAS is a Gold Microsoft Partner and provides the QUMAS Compliance Platform on SharePoint 2010, Documentum, Oracle or SQL. For more information, visit www.qumas.com.

About Accelrys

QUMAS is an Accelrys company. Accelrys (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific foundation optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, QA/QC and manufacturing phases of product development. Accelrys offers capabilities in scientific data management, modeling and simulation, research informatics, laboratory informatics, enterprise quality management, environmental health & safety and operations intelligence for customers in science-driven industries. Using Accelrys technology, scientific innovators can access, organize, analyze and share data in unprecedented ways across the research, laboratory and manufacturing continuum, ultimately enhancing innovation, improving productivity and compliance, reducing costs and accelerating product development from research to manufacturing.

Accelrys solutions are used by more than 2,000 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, Calif., Accelrys employs approximately 225 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.

All trade names, trademarks, and service marks are rightful property of their respective owners.


MEDIA CONTACT:
Caoimhe Kiely
VP Marketing
QUMAS
+353 21 4915100
Email Contact
www.qumas.com



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES